FIELD: medicine.
SUBSTANCE: invention relates to pharmaceutical compositions containing CNP variant peptides for the treatment of skeletal dysplasias, one or more symptoms of skeletal dysplasias such as long bone growth or growth rate, and other disorders having skeletal dysplasia and/or a CNP-associated symptom or component.
EFFECT: obtaining a method of treatment of skeletal dysplasia.
45 cl, 1 tbl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| APPLICATION OF VARIANTS OF NATRIURETIC PEPTIDE OF C-TYPE FOR TREATMENT OF SKELETAL DYSPLASIA | 2016 |
|
RU2728567C2 |
| VERSIONS OF C-TYPE NATRIURETIC PEPTIDE | 2010 |
|
RU2573911C2 |
| POLYPEPTIDES THAT ARE SOLUBLE RECEPTORS OF FIBROBLAST GROWTH FACTOR 3 (sFGFR3), AND WAYS OF THEIR APPLICATION | 2017 |
|
RU2751483C2 |
| USE OF OPTIONS OF NATRIURETIC PEPTIDE OF TYPE C FOR TREATMENT OF OSTEOARTHRITIS | 2016 |
|
RU2759679C2 |
| CNP PRODRUGS | 2016 |
|
RU2824988C1 |
| APPLICATION OF GROWTH HORMONE FRAGMENTS | 2012 |
|
RU2639474C2 |
| LONG-ACTING POLYPEPTIDES AND METHODS OF THEIR PRODUCTION AND ADMINISTRATION | 2014 |
|
RU2798845C2 |
| LONG-ACTING POLYPEPTIDES AND METHODS OF THEIR PREPARATION AND ADMINISTRATION | 2014 |
|
RU2746943C2 |
| ANTIBODIES TO B7-H1 AND CTLA-4 FOR THE TREATMENT OF NON-SMALL CELL LUNG CANCER | 2015 |
|
RU2806210C2 |
| TREATMENT AND FUNCTIONAL CURE OF HIV-INFECTION WITH MONOCLONAL ANTIBODIES TO CD4 MEDIATING COMPETITIVE INHIBITION OF HIV ENTRY | 2014 |
|
RU2762315C2 |
